UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

ESR1 Methylation: A Liquid Biopsy-Based Epigenetic Assay for the Follow-up of Patients with Metastatic Breast Cancer Receiving Endocrine Treatment

Clinical cancer research, 2018-03, Vol.24 (6), p.1500-1510

2018

Volltextzugriff (PDF)

PIK3CA hotspot mutations in circulating tumor cells and paired circulating tumor DNA in breast cancer: a direct comparison study

Molecular oncology, 2019-12, Vol.13 (12), p.2515-2530

2019

Volltextzugriff (PDF)

Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data

The lancet oncology, 2014-04, Vol.15 (4), p.406-414

2014

Volltextzugriff (PDF)

Gene expression profile of circulating tumor cells in breast cancer by RT-qPCR

BMC cancer, 2011-10, Vol.11 (1), p.422-422, Article 422

2011

Volltextzugriff (PDF)

Phenotypic characterization of circulating tumor cells in the peripheral blood of patients with small cell lung cancer

PloS one, 2017-07, Vol.12 (7), p.e0181211-e0181211

2017

Volltextzugriff (PDF)

Assessment of the Efficacy and Clinical Utility of Different Circulating Tumor Cell (CTC) Detection Assays in Patients with Chemotherapy-Naïve Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

International journal of molecular sciences, 2021-01, Vol.22 (2), p.925

2021

Volltextzugriff (PDF)

Different Prognostic Value of Cytokeratin-19 mRNA–Positive Circulating Tumor Cells According to Estrogen Receptor and HER2 Status in Early-Stage Breast Cancer

Journal of clinical oncology, 2007-11, Vol.25 (33), p.5194-5202

2007

Volltextzugriff (PDF)

A Comparison of Three Methods for the Detection of Circulating Tumor Cells in Patients with Early and Metastatic Breast Cancer

Cellular physiology and biochemistry, 2017-12, Vol.44 (2), p.594-606

2017

Volltextzugriff (PDF)

Dynamic changes of CTCs in patients with metastatic HR(+)/HER2(−) breast cancer receiving salvage treatment with everolimus/exemestane

Cancer chemotherapy and pharmacology, 2021-02, Vol.87 (2), p.277-287

2021

Volltextzugriff (PDF)

International study on inter-reader variability for circulating tumor cells in breast cancer

Breast cancer research : BCR, 2014-04, Vol.16 (2), p.R43-R43, Article R43

2014

Volltextzugriff (PDF)

Epithelial-to-mesenchymal transition of tumor cells: cancer progression and metastasis

The International journal of developmental biology, 2022, Vol.66 (1-2-3), p.277-283

2022

Volltextzugriff (PDF)

Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients

Breast cancer research : BCR, 2011-06, Vol.13 (3), p.R59-R59, Article R59

2011

Volltextzugriff (PDF)

Variable expression levels of keratin and vimentin reveal differential EMT status of circulating tumor cells and correlation with clinical characteristics and outcome of patients with metastatic breast cancer

BMC cancer, 2015-05, Vol.15 (1), p.399-399, Article 399

2015

Volltextzugriff (PDF)

Characterization of DLL3-positive circulating tumor cells (CTCs) in patients with small cell lung cancer (SCLC) and evaluation of their clinical relevance during front-line treatment

Lung cancer (Amsterdam, Netherlands), 2019-09, Vol.135, p.33-39

2019

Volltextzugriff (PDF)

Bcl-2 expression in circulating tumor cells (CTCs) of patients with small cell lung cancer (SCLC) receiving front-line treatment

Lung cancer (Amsterdam, Netherlands), 2018-10, Vol.124, p.270-278

2018

Volltextzugriff (PDF)

The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper

Critical reviews in oncology/hematology, 2019-02, Vol.134, p.39-45

2019

Volltextzugriff (PDF)

Characterization of DLL3-positive circulating tumor cells (CTCs) in patients with small cell lung cancer (SCLC) and evaluation of their clinical relevance during front-line treatment

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e20086-e20086

2019

Volltextzugriff (PDF)

A Comprehensive Molecular Analysis of in Vivo Isolated EpCAM-Positive Circulating Tumor Cells in Breast Cancer

Clinical chemistry (Baltimore, Md.), 2021-10, Vol.67 (10), p.1395-1405

2021

Volltextzugriff (PDF)

Abstract 1725: Detection of ESR1 D538G mutation in circulating tumor cells (CTCs) and paired circulating tumor DNA (ctDNA) samples of breast cancer patients

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.1725-1725

2017

Volltextzugriff (PDF)

TTF-1- and/or CD56-positive Circulating Tumor Cells in patients with small cell lung cancer (SCLC)

Scientific reports, 2017-03, Vol.7 (1), p.45351-45351, Article 45351

2017

Volltextzugriff (PDF)

Abstract 4577: ESR1 methylation: A liquid biopsy-based epigenetic assay for the follow up of patients with metastatic breast cancer receiving endocrine treatment

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.4577-4577

2018

Volltextzugriff (PDF)

PIK 3 CA hotspot mutations in circulating tumor cells and paired circulating tumor DNA in breast cancer: a direct comparison study

Molecular oncology, 2019-12, Vol.13 (12), p.2515-2530

2019

Volltextzugriff (PDF)

Prognostic value of circulating tumor cells in non-small cell lung cancer

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e20520-e20520

2017

Volltextzugriff (PDF)

Abstract 1730: ESR1 methylation in circulating tumor cells, ctDNA and primary tumors of breast cancer patients

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.1730-1730

2017

Volltextzugriff (PDF)

Dynamic changes of phenotypically different circulating tumor cells sub-populations in patients with recurrent/refractory small cell lung cancer treated with pazopanib

Scientific reports, 2018-02, Vol.8 (1), p.2238-9, Article 2238

2018

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(34)

Publikationsform

Sprache

Englisch
(35)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(21)
Life Sciences & Biomedicine
(17)
Female
(14)
Humans
(14)
Oncology
(14)
Breast Cancer
(11)
Aged
(10)
Adult
(9)
Breast Neoplasms - Pathology
(9)
Middle Aged
(9)
Neoplastic Cells, Circulating - Metabolism
(9)
Neoplastic Cells, Circulating - Pathology
(8)
Tumor Cells
(8)
Aged, 80 And Over
(7)
Tumors
(7)
Cell Line, Tumor
(6)
Chemotherapy
(6)
Circulating Tumor Cells
(6)
Metastases
(6)
Metastasis
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

ESR1 Methylation: A Liquid Biopsy-Based Epigenetic Assay for the Follow-up of Patients with Metastatic Breast Cancer Receiving Endocrine Treatment

PIK3CA hotspot mutations in circulating tumor cells and paired circulating tumor DNA in breast cancer: a direct comparison study

Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data

Gene expression profile of circulating tumor cells in breast cancer by RT-qPCR

Phenotypic characterization of circulating tumor cells in the peripheral blood of patients with small cell lung cancer

Assessment of the Efficacy and Clinical Utility of Different Circulating Tumor Cell (CTC) Detection Assays in Patients with Chemotherapy-Naïve Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Different Prognostic Value of Cytokeratin-19 mRNA–Positive Circulating Tumor Cells According to Estrogen Receptor and HER2 Status in Early-Stage Breast Cancer

A Comparison of Three Methods for the Detection of Circulating Tumor Cells in Patients with Early and Metastatic Breast Cancer

Dynamic changes of CTCs in patients with metastatic HR(+)/HER2(−) breast cancer receiving salvage treatment with everolimus/exemestane

International study on inter-reader variability for circulating tumor cells in breast cancer

Epithelial-to-mesenchymal transition of tumor cells: cancer progression and metastasis

Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients

Variable expression levels of keratin and vimentin reveal differential EMT status of circulating tumor cells and correlation with clinical characteristics and outcome of patients with metastatic breast cancer

Characterization of DLL3-positive circulating tumor cells (CTCs) in patients with small cell lung cancer (SCLC) and evaluation of their clinical relevance during front-line treatment

Bcl-2 expression in circulating tumor cells (CTCs) of patients with small cell lung cancer (SCLC) receiving front-line treatment

The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper

Characterization of DLL3-positive circulating tumor cells (CTCs) in patients with small cell lung cancer (SCLC) and evaluation of their clinical relevance during front-line treatment

A Comprehensive Molecular Analysis of in Vivo Isolated EpCAM-Positive Circulating Tumor Cells in Breast Cancer

Abstract 1725: Detection of ESR1 D538G mutation in circulating tumor cells (CTCs) and paired circulating tumor DNA (ctDNA) samples of breast cancer patients

TTF-1- and/or CD56-positive Circulating Tumor Cells in patients with small cell lung cancer (SCLC)

Abstract 4577: ESR1 methylation: A liquid biopsy-based epigenetic assay for the follow up of patients with metastatic breast cancer receiving endocrine treatment

PIK 3 CA hotspot mutations in circulating tumor cells and paired circulating tumor DNA in breast cancer: a direct comparison study

Prognostic value of circulating tumor cells in non-small cell lung cancer

Abstract 1730: ESR1 methylation in circulating tumor cells, ctDNA and primary tumors of breast cancer patients

Dynamic changes of phenotypically different circulating tumor cells sub-populations in patients with recurrent/refractory small cell lung cancer treated with pazopanib

Suchergebnisse filtern